RARRES2 is involved in the "lock-and-key" interactions between osteosarcoma stem cells and tumor-associated

Jingjin Ma1, Zhiyu Chen1, Qiaochu Li1

  • 1Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.

Scientific Reports
|January 27, 2024
PubMed

Insights

Osteosarcoma stem cells (OSCs) drive drug resistance and recurrence. This study reveals heterogeneity in OSCs and identifies the IGF-RARRES2 axis, involving tumor-associated macrophages, as crucial for maintaining OSC stemness.

Area of Science:

  • Oncology
  • Immunology
  • Genetics

Background:

  • Osteosarcoma (OS) is a primary bone malignancy.
  • Osteosarcoma stem cells (OSCs) contribute to therapeutic resistance, disease recurrence, and immune suppression.
  • Understanding OSC heterogeneity and their interaction with the tumor microenvironment is critical for developing effective treatments.

Purpose of the Study:

  • To investigate the heterogeneity of OSCs within the OS tumor microenvironment.
  • To elucidate the immunosuppression mechanisms driven by the interaction between OSCs and tumor-associated macrophages (TAMs).
  • To identify key molecular players and communication pathways involved in OSC stemness maintenance.

Main Methods:

  • Single-cell transcriptomics was employed to analyze OS cell components, trajectory, and intercellular communication.
  • Computational analysis identified cell communication patterns, hub genes, and malignant cell subgroups, including OSCs.
  • In vitro and patient studies validated key findings, including the role of specific genes and cytokines.

Main Results:

  • OSCs exhibit significant heterogeneity, with distinct subgroups involved in proliferation and intercellular communication.
  • The study identified RARRES2 as a key gene mediating communication between OSCs and TAMs.
  • Tumor-associated macrophages promote OSC stemness via insulin-like growth factor 1 (IGF-1) signaling, which upregulates RARRES2.

Conclusions:

  • The IGF-1/RARRES2 axis is a critical pathway for maintaining OSC stemness through communication with TAMs.
  • RARRES2 serves as a potential biomarker for osteosarcoma.
  • Targeting the identified communication pathways may offer novel therapeutic strategies for osteosarcoma.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K